Kedrion Biopharma

Melville still gets Italian pharma’s blood pumping

By GREGORY ZELLER // A Long Island biotech with Italian roots will stay in Melville as it grows its family. Based in the Tuscany town of Barga, Italy, Kedrion Biopharma is investing $30 million to renovate its only U.S. production facility, a 105,000-square-foot-complex on 11 acres in Melville. The company – which manufactures plasma-derived therapies for patients with debilitating conditions like hemophilia and immune deficiencies – will rely on production facilities in Italy and Hungary…